YH35324
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for YH35324, covering 2024-11-22 to 2025-01-24. Get the full timeline:
Most recent: Clinical Trial Update: A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases [Phase 1]